Australian Pharmaceuticals & Biotech Best Growth Stocks

Botanix Pharmaceuticals

Market Cap: AU$313.8m

Operates as a commercial dermatology company in Australia and the United States.

EZZ Life Science Holdings

Market Cap: AU$107.1m

Engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and South-East Asia.

Mesoblast

Market Cap: AU$3.0b

Engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland.

Clinuvel Pharmaceuticals

Market Cap: AU$591.5m

A biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.

Alterity Therapeutics

Market Cap: AU$97.9m

Engages in the research and development of therapeutic drugs to treat Alzheimer’s disease, Huntington disease, Parkinson’s disease, and other neurological disorders in Australia.

Medical Developments International

Market Cap: AU$80.6m

Manufactures and distributes emergency medical solutions in Australia, Asia, Europe, the United States, and internationally.

Aroa Biosurgery

Market Cap: AU$224.3m

Develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally.

Mayne Pharma Group

Market Cap: AU$418.4m

A specialty pharmaceutical company, focuses on the commercialization of women’s health and dermatology pharmaceuticals in Australia, New Zealand, the United States, Canada, Europe, Asia, and internationally.

Trajan Group Holdings

Market Cap: AU$120.5m

Develops, manufactures, and sells analytical and life science products and devices in Malaysia, Japan, Australia, New Zealand, the United States, Europe, the Middle East, Africa, and India.